Glycoprotein inhibitors and fibrinolysis in myocardial infarction.
作者信息
Ring B L
出版信息
JAMA. 2000 Dec 27;284(24):3124-5. doi: 10.1001/jama.284.24.3124.
PMID:11135766
Abstract
摘要
相似文献
1
Glycoprotein inhibitors and fibrinolysis in myocardial infarction.
JAMA. 2000 Dec 27;284(24):3124-5. doi: 10.1001/jama.284.24.3124.
2
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
Eur Heart J. 1998 Nov;19(11):1608-16. doi: 10.1053/euhj.1998.1222.
3
Use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Am J Med Sci. 1997 Jul;314(1):31-6. doi: 10.1097/00000441-199707000-00007.
4
[Impact of GP IIb/IIIa antagonists in interventional cardiology].
Dtsch Med Wochenschr. 2003 Feb 7;128(6):281-7. doi: 10.1055/s-2003-37078.
5
Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery.
Circulation. 1998 Sep 22;98(12):1249-50. doi: 10.1161/01.cir.98.12.1249.
6
7
The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
J Am Coll Cardiol. 2008 Feb 5;51(5):536-7. doi: 10.1016/j.jacc.2007.10.025.
8
Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
J Interv Cardiol. 2008 Apr;21(2):118-21. doi: 10.1111/j.1540-8183.2007.00344.x.
9
Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty.
Am J Cardiol. 2002 Sep 1;90(5):533-6. doi: 10.1016/s0002-9149(02)02530-4.
10
[Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
Vojnosanit Pregl. 2001 Jan-Feb;58(1):65-72.
Zotero 插件